Equillium (EQ) Total Non-Current Liabilities (2017 - 2021)

Equillium (EQ) reported Total Non-Current Liabilities of $16.7 million for Q3 2021, up 17.36% year-over-year from $14.2 million in Q3 2020, and up 10.66% quarter-over-quarter from $15.0 million in Q2 2021.

Equillium (EQ) Total Non-Current Liabilities (2017 - 2021) Analysis & Trends

Equillium (EQ) has 5 years of Total Non-Current Liabilities data on file, last reported at $16.7 million in Q3 2021.

  • Total Non-Current Liabilities for Q3 2021 came in at $16.7 million, up 17.36% year-over-year; the trailing twelve-month figure through Sep 2021 was $16.7 million (up 17.36% YoY), and the FY2020 annual result was $15.5 million, up 14.42% from the prior year.
  • Total Non-Current Liabilities grew to $16.7 million in Q3 2021 per EQ's latest filing, from $15.0 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $16.7 million in Q3 2018 and troughed at $163000.0 in Q2 2019.
  • A 5-year average of $11.2 million and a median of $13.7 million in 2019 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2018 and 2020: Total Non-Current Liabilities sank 97.68% in 2018, then soared 7996.32% in 2020.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $8.6 million in 2017, then slumped by 97.68% to $200000.0 in 2018, then soared by 6682.0% to $13.6 million in 2019, then gained by 14.42% to $15.5 million in 2020, then climbed by 7.29% to $16.7 million in 2021.
  • Business Quant data shows EQ's Total Non-Current Liabilities at $16.7 million in Q3 2021, $15.0 million in Q2 2021, and $14.9 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Equillium 293.17 Mn 232.78 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2021 16.65 Mn
Jun 30, 2021 15.05 Mn
Mar 31, 2021 14.92 Mn
Dec 31, 2020 15.52 Mn
Sep 30, 2020 14.19 Mn
Jun 30, 2020 13.20 Mn
Mar 31, 2020 13.46 Mn
Dec 31, 2019 13.56 Mn
Sep 30, 2019 13.89 Mn
Jun 30, 2019 163,000.00
Mar 31, 2019 181,000.00
Dec 31, 2018 200,000.00
Sep 30, 2018 16.65 Mn
Dec 31, 2017 8.63 Mn